en

PRODUCT DETAIL

Imlygic

Code 7821B
MA number EU/1/15/1064/002
Product Form: sol inj 1x1 ml/10e8 PFU (liek.inj.cykloolefín.polymér)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XX Other antineoplastic agents
L01XX51 Talimogene laherparepvec
Shelf life: 60
Container: vial
Route of admin.: Intralesional use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 16.12.2015
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 23.11.2020
eu-flag.png sk-flag.png